Research Topic · Peer-Reviewed

Monoclonal Antibodies

Monoclonal antibodies (mAbs) are antibody molecules that are identical due to being derived from a single B-cell clone. They are used to specifically recognise and bind to antigens, which are substances that are recognised as foreign by an organism's immune system. mAbs have become an important tool in diagnostics, …

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 72× across the literature 🗓 Reviewed June 2026

Overview

Monoclonal antibodies (mAbs) are antibody molecules that are identical due to being derived from a single B-cell clone. They are used to specifically recognise and bind to antigens, which are substances that are recognised as foreign by an organism's immune system. mAbs have become an important tool in diagnostics, therapeutics and research, being used in a wide variety of fields such as oncology, neurology and vaccines. They are used to detect and sometimes even treat diseases, and have been used to make advances in the diagnosis and treatment of several types of cancer. mAbs can also be used to improve vaccine efficacy, targeting and delivery, as well as to inform mechanistic and molecular insights into immunobiology and disease.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 12 articles above have been cited 72 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Monoclonal Antibodies, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Migraine Management.

Journal editorial board
Jing Xiang · United States Frederick Freitag · United States Yohannes W. Woldeamanuel · United States

This page summarises published research for orientation; it is not medical or professional advice.